ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

CELU Celularity Inc

3.29
0.17 (5.45%)
시간외 거래
최종 업데이트: 05:30:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Celularity Inc CELU 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.17 5.45% 3.29 05:30:00
개장가 저가 고가 종가 전일 종가
3.21 3.08 3.32 3.29 3.12
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
22/04/202421:00GLOBECelularity Inc. to Host Investor and Analyst Research &..
20/04/202406:30GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
19/04/202405:30GLOBECelularity Abstract “Emerging Technologies for the..
15/04/202421:00GLOBECelularity Announces Net Sales Trending Ahead of..
08/04/202422:00GLOBECelularity to Present Data Showing Senescent Cell..
26/03/202422:00GLOBECelularity Receives Healthcare Common Procedure Coding..
20/03/202422:15GLOBECelularity Submits Request to U.S. FDA for Orphan Drug..
14/03/202422:15GLOBECelularity CEO to Present on Cell Therapy’s Potential to..
12/03/202422:20GLOBECelularity CEO to Present Keynote Address at 2024 Society..
07/03/202423:35GLOBECelularity to Present Data Showing Cancer Tumor Reduction by..
27/02/202407:15EDGAR2Form 8-K - Current report
24/02/202406:10GLOBECelularity Announces 1-for-10 Reverse Stock Split
22/02/202423:05EDGAR2Form 8-K - Current report
22/02/202411:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:05GLOBECelularity’s Tri-layer Decellularized, Dehydrated Human..
13/02/202406:15EDGAR2Form 8-K - Current report
02/02/202420:01EDGAR2Form DEF 14A - Other definitive proxy statements
01/02/202423:00GLOBECelularity Announces Net Sales Expectations for First..
25/01/202423:00GLOBECelularity and Genting Leaders Comments on Closing $21..
23/01/202420:02EDGAR2Form PRE 14A - Other preliminary proxy statements
19/01/202403:40GLOBECelularity Releases CEO Letter to Shareholders
18/01/202407:15EDGAR2Form SC 13D/A - General statement of acquisition of..
18/01/202406:14EDGAR2Form 8-K - Current report
10/01/202406:49EDGAR2Form 8-K - Current report
05/01/202403:00GLOBECelularity Confirms Commercialization Agreement with..
04/01/202402:00GLOBECelularity Announces Net Sales and Total Revenue..
30/12/202306:47EDGAR2Form 8-K - Current report
25/11/202303:46EDGAR2Form 8-K - Current report
25/11/202303:15GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
18/10/202322:00GLOBECelularity Announces Commercial Biomaterial Products..
17/10/202309:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202308:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/09/202322:25EDGAR2Form 8-K - Current report
08/09/202305:21EDGAR2Form 8-K - Current report
08/09/202305:10GLOBECelularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to..
29/08/202322:15EDGAR2Form 8-K - Current report
29/08/202322:00GLOBECelularity Announces Multi-Year Research Collaboration..
26/08/202305:06EDGAR2Form 8-K - Current report
15/08/202306:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/08/202305:16EDGAR2Form 8-K - Current report
29/07/202305:27EDGAR2Form 8-K - Current report
29/07/202305:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/07/202322:07GLOBECelularity Inc. Announces $3 Million Registered Direct..
27/07/202322:00GLOBECelularity and Verséa Ophthalmics Announce Exclusive U.S...
20/07/202301:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/07/202322:00GLOBECelularity Human Placental-Derived Advanced Biomaterials..

최근 히스토리

Delayed Upgrade Clock